Colgate-Palmolive (India) share price falls 0.37% May 2026

Price check: Colgate-Palmolive (India) ends lower

Colgate-Palmolive (India) Ltd’s share price traded lower on Friday, May 22, 2026, with the stock last quoted around ₹2,156.90 at 03:59 PM IST. Data points in the input indicate a decline of about 0.37% from the previous close of ₹2,164.90. Another market snapshot in the same input showed the stock at ₹2,157.00, down 0.34% versus a previous close of ₹2,164.40. Despite minor differences across snapshots, both indicate a mild decline for the session.

Intraday range signals limited follow-through

The stock was reported to have traded within an intraday range of ₹2,190.50 (high) and ₹2,132.00 (low). That band suggests active two-way trade but no decisive breakout within the session, based on the provided figures. The move also comes amid commentary about weak price momentum and bearish technical signals in some third-party assessments.

Coverage and consensus: 28 analysts, average rating ‘Hold’

The input states that 28 analysts have initiated coverage on Colgate-Palmolive (India) Ltd. Within that universe, 2 analysts have a “strong buy” rating and 4 analysts have a “buy” rating. The same dataset also notes that 8 analysts have a “sell” rating. The average broker rating mentioned is “Hold,” which broadly fits a market stance where the stock is tracked actively but not seen as a clear near-term upside bet at current levels.

MarketsMOJO stance: Sell signals built on four parameters

MarketsMOJO commentary in the input describes the stock’s technical outlook as bearish, citing stretched valuation, declining profitability, and weak price momentum. It also says the company’s “quality” has declined due to weakening profitability and operational efficiency, while the financial trend is described as negative with disappointing quarterly results and sluggish long-term growth. The technical indicators are said to reflect underperformance and negative momentum compared to the broader market.

Separately, the same input includes multiple references to MarketsMOJO rating changes. It says the stock was downgraded to a “Strong Sell” rating by MarketsMOJO on March 11, 2026, and that the rating was later revised from “Strong Sell” to “Sell” on February 3, 2026, implying at least one rating action sequence captured from different points in time. Readers should note that these statements appear in the provided text as-is and are best interpreted as a record of shifting model outputs rather than a single continuous narrative.

Broker notes: Nomura cuts target, keeps Reduce

Among broker updates cited, Nomura adjusted Colgate-Palmolive (India)’s price target to ₹2,050 from ₹2,200 and maintained a “Reduce” stance (dated 02/02 in the provided table). The same broker history list in the input also includes:

• Jan. 30: Nomura raised the target to ₹2,500 from ₹2,450 and kept a “Buy” rating.
• 25-10-24: Nomura adjusted the target to ₹2,200 from ₹2,350 and kept “Reduce.”

This mix of upgrades and cuts over time indicates that brokerage views have varied meaningfully across different dates, even within a single institution, depending on earnings context and valuation assumptions.

Other cautious calls: ICICI Securities and Emkay maintain Sell

The input also highlights continued caution from domestic brokerages after a muted Q3FY26 performance. ICICI Securities reiterated a “Sell” rating and assigned a DCF-based target price of ₹1,800 per share, citing structural challenges. Emkay Global maintained a “Sell” rating with a Dec-26E target price of ₹2,000, and the note mentioned this was based on a 35x P/E, described as about a 20% discount to the last five-year average forward P/E.

On January 30, 2026, Colgate-Palmolive (India) shares were cited as trading 0.28% lower at ₹2,105.90 on the BSE at 09:24 AM, with the same section noting persistent volume pressure and lack of a sustained demand-led recovery in the core oral care category.

Snapshot of key facts (as provided)

Target and rating trail mentioned in the input

Market impact: what investors are reacting to

The immediate market impact in the provided data is modest on the day, with the stock down about 0.34% to 0.37% around the ₹2,157 level. Still, the broader tone of the commentary is cautious due to a combination of “very expensive” valuation grades (as stated), negative financial trend commentary, and weak technical signals. The Q3FY26 context cited by analysts also points to volume pressures and structural challenges in the core oral care category, which is central to the company’s business.

The input also mentions “significant put option trading” around the stock as a signal of bearish sentiment. While the text does not provide quantities or strike details, the inclusion reinforces that positioning and sentiment indicators have turned cautious, aligning with multiple Sell/Reduce calls.

Why the story matters: valuation versus execution debate

For a widely tracked FMCG name, the key issue highlighted here is the tension between strong brand quality perceptions and the market’s demand for consistent volume-led growth. MarketsMOJO’s framework, as described, flags weakening profitability and operational efficiency, and considers the technical trend to be negative. Broker notes from ICICI Securities and Emkay emphasize structural challenges and persistent volume pressures, while also anchoring targets well below the prevailing trading levels cited in May 2026.

At the same time, the distribution of analyst ratings and an average “Hold” suggests the broader Street is not uniformly bearish. The spread in price targets and periodic changes in Nomura’s stance underline how sensitive the investment case can be to valuation multiples, earnings momentum, and expectations of demand recovery.

Conclusion

Colgate-Palmolive (India) traded marginally lower around ₹2,157 on May 22, 2026, with the stock moving within ₹2,190.50 to ₹2,132.00 during the session. Analyst commentary in the input remains cautious, with multiple Sell/Reduce stances and valuation concerns flagged alongside soft demand and technical weakness. The next set of broker revisions and company results commentary are likely to be the key checkpoints for whether sentiment stabilises or remains defensive.